Literature DB >> 22282137

ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis.

Tadashi Shimoyama1, Masahiko Aoki, Yoshihiro Sasaki, Masashi Matsuzaka, Shigeyuki Nakaji, Shinsaku Fukuda.   

Abstract

A combination of the detection of serum anti-Helicobacter pylori antibody and measurement of the level of serum pepsinogens (PG)s, known as the ABC method, has been used in screening for gastric cancer. The ABC method has been shown to be useful in urban and/or younger populations. The aim of this study was to assess whether this method is applicable for an agricultural population with a high incidence of gastric cancer. In all, 1048 healthy adults (401 men and 647 women) who participated in a mass survey in April 2005 were examined. Their serum samples were tested to determine the prevalence of anti-H. pylori antibody, and the levels of PG I and PG II were also measured to assess the presence of atrophic gastritis. Of the elderly subjects born before 1940, 59.4% were classified into groups C and D, with a high risk for gastric cancer, and only 22.7% were classified into group A, with the lowest risk. Of the middle-aged subjects born in the 1940s and the 1950s, 66.5% were classified into groups B-D. If the ABC method is performed in the mass screening for gastric cancer in this population, a large number of subjects will be identified for further examinations. The applicability of the ABC method should be evaluated before use in the screening for gastric cancer, particularly in an aging population with a high prevalence of H. pylori infection and atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282137     DOI: 10.1007/s10120-012-0141-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  10 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

Review 2.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

3.  A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication.

Authors:  Takashi Kawai; Kohei Kawakami; Taku Kudo; Shoji Ogiahara; Yutaka Handa; Fuminori Moriyasu
Journal:  Intern Med       Date:  2002-10       Impact factor: 1.271

4.  Most gastric cancer occurs on the distal side of the endoscopic atrophic border.

Authors:  T Yoshimura; T Shimoyama; S Fukuda; M Tanaka; A T Axon; A Munakata
Journal:  Scand J Gastroenterol       Date:  1999-11       Impact factor: 2.423

5.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

7.  Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies.

Authors:  Kazuhiko Inoue; Tomoo Fujisawa; Ken Haruma
Journal:  Int J Biol Markers       Date:  2010 Oct-Dec       Impact factor: 2.659

8.  The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study.

Authors:  Yoshinori Oishi; Yutaka Kiyohara; Michiaki Kubo; Keiichi Tanaka; Yumihiro Tanizaki; Toshiharu Ninomiya; Yasufumi Doi; Kentaro Shikata; Koji Yonemoto; Tomoko Shirota; Takayuki Matsumoto; Mitsuo Iida
Journal:  Am J Epidemiol       Date:  2006-01-27       Impact factor: 4.897

Review 9.  The Japanese guidelines for gastric cancer screening.

Authors:  Chisato Hamashima; Daisuke Shibuya; Hideo Yamazaki; Kazuhiko Inoue; Akira Fukao; Hiroshi Saito; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2008-03-14       Impact factor: 3.019

10.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.

Authors:  Hiroshi Ohata; Shintaro Kitauchi; Noriko Yoshimura; Kouichi Mugitani; Masataka Iwane; Hideya Nakamura; Akiyoshi Yoshikawa; Kimihiko Yanaoka; Kenji Arii; Hideyuki Tamai; Yasuhito Shimizu; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

  10 in total
  10 in total

1.  Serum pepsinogen II is a better diagnostic marker in gastric cancer.

Authors:  Xue-Yuan Cao; Zhi-Fang Jia; Mei-Shan Jin; Dong-Hui Cao; Fei Kong; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

2.  Detection of gastritis by a deep convolutional neural network from double-contrast upper gastrointestinal barium X-ray radiography.

Authors:  Ren Togo; Nobutake Yamamichi; Katsuhiro Mabe; Yu Takahashi; Chihiro Takeuchi; Mototsugu Kato; Naoya Sakamoto; Kenta Ishihara; Takahiro Ogawa; Miki Haseyama
Journal:  J Gastroenterol       Date:  2018-10-03       Impact factor: 7.527

3.  Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels.

Authors:  Sana Eybpoosh; Yeganeh Talebkhan; Samaneh Saberi; Maryam Esmaeili; Akbar Oghalaie; Fatemeh Ebrahimzadeh; Toktam Karimi; Afshin Abdirad; Azin Nahvijou; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hosseini; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2015-06-28

4.  Changing trends in the prevalence of H. pylori infection in Japan (1908-2003): a systematic review and meta-regression analysis of 170,752 individuals.

Authors:  Chaochen Wang; Takeshi Nishiyama; Shogo Kikuchi; Manami Inoue; Norie Sawada; Shoichiro Tsugane; Yingsong Lin
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

5.  Preliminary study of automatic gastric cancer risk classification from photofluorography.

Authors:  Ren Togo; Kenta Ishihara; Katsuhiro Mabe; Harufumi Oizumi; Takahiro Ogawa; Mototsugu Kato; Naoya Sakamoto; Shigemi Nakajima; Masahiro Asaka; Miki Haseyama
Journal:  World J Gastrointest Oncol       Date:  2018-02-15

6.  Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population.

Authors:  Chikara Iino; Tadashi Shimoyama; Daisuke Chinda; Tetsu Arai; Daisuke Chiba; Shigeyuki Nakaji; Shinsaku Fukuda
Journal:  Front Immunol       Date:  2018-04-06       Impact factor: 7.561

7.  Lifestyle Factors Rather Than Helicobacter pylori Infection or Estradiol Level are Associated With Osteopenia in Japanese Men.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Kaori Sawada; Chikara Iino; Hirotake Sakuraba; Shigeyuki Nakaji; Shinsaku Fukuda
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

8.  The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.

Authors:  Hongzhang Shen; Kangwei Xiong; Xiangyu Wu; Sile Cheng; Qifeng Lou; Hangbin Jin; Xiaofeng Zhang
Journal:  Gastroenterol Res Pract       Date:  2021-04-12       Impact factor: 2.260

9.  Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits.

Authors:  Qingjie Zhou; Yihan Chen; Jie Pan; Leying Zhou; Jiejun Lin
Journal:  BMC Gastroenterol       Date:  2022-05-08       Impact factor: 2.847

Review 10.  Helicobacter pylori Antibody Titer and Gastric Cancer Screening.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Sakiko Takarabe; Shogo Kaida; Jiro Nishida
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.